NCT04780698

DCI COVID-19 Surveillance Project

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Temple University · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective longitudinal census study conducted at a single center (DCI Inc., Henry Avenue, Philadelphia). The purpose of this study is to gain information about COVID-19 infection and antibody response in an in-center dialysis population. The investigators hypothesize that screening and surveillance for COVID-19 positive test (viral infection) and antibodies response to infection (potential immunity) in a dialysis center population within a high-prevalence region can provide foundational information to guide approaches toward prevention of COVID-19 related illness in a susceptible population. Participants will be given a questionnaire initially and monthly over the study period to find out whether they have had COVID-19 infection, hospitalization, or symptoms. A nasopharyngeal swab test for COVID-19 infection and a blood sample for COVID-19 antibody will be collected monthly for the study period.

Conditions

• Covid19

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection	COVID-19 infection and antibody testing

Timeline

• Start date: 2021-02-12
• Primary completion: 2022-10-13
• Completion: 2022-10-13
• First posted: 2021-03-03
• Last updated: 2023-02-16

Locations

1 site across 1 country: United States